Law360, New York (October 12, 2009, 7:59 PM EDT) -- Positioning itself to become a leading provider of certain common chemotherapy agents, plant culture technology company Phyton Biotech LLC announced Monday that it had purchased the intellectual property and other assets of Natural Pharmaceuticals Inc., a major manufacturer of cancer treatment ingredients derived from yew trees.
Phyton — an affiliate of German firm Phyton Biotech GmbH and DFB Pharmaceuticals Inc. — and Beverley, Mass.-based Natural Pharmaceuticals declined to disclose the financial terms of the deal.
The companies are privately held, and no details were filed with...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.